Annual CFF
$45.10 M
-$196.35 M-81.32%
December 31, 2023
Summary
- As of February 8, 2025, PRTA annual cash flow from financing activities is $45.10 million, with the most recent change of -$196.35 million (-81.32%) on December 31, 2023.
- During the last 3 years, PRTA annual CFF has risen by +$44.89 million (+20878.14%).
- PRTA annual CFF is now -81.32% below its all-time high of $241.46 million, reached on December 31, 2022.
Performance
PRTA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$333.00 K
-$111.00 K-25.00%
September 30, 2024
Summary
- As of February 8, 2025, PRTA quarterly cash flow from financing activities is $333.00 thousand, with the most recent change of -$111.00 thousand (-25.00%) on September 30, 2024.
- Over the past year, PRTA quarterly CFF has dropped by -$150.00 thousand (-31.06%).
- PRTA quarterly CFF is now -99.85% below its all-time high of $220.76 million, reached on December 31, 2022.
Performance
PRTA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$2.10 M
-$2.38 M-53.15%
September 30, 2024
Summary
- As of February 8, 2025, PRTA TTM cash flow from financing activities is $2.10 million, with the most recent change of -$2.38 million (-53.15%) on September 30, 2024.
- Over the past year, PRTA TTM CFF has dropped by -$43.01 million (-95.35%).
- PRTA TTM CFF is now -99.25% below its all-time high of $280.80 million, reached on June 30, 2023.
Performance
PRTA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PRTA Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -81.3% | -31.1% | -95.3% |
3 y3 years | +10000.0% | -99.6% | -98.9% |
5 y5 years | +12.6% | +100.0% | +819.3% |
PRTA Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -81.3% | at low | -99.8% | at low | -99.3% | at low |
5 y | 5-year | -81.3% | >+9999.0% | -99.8% | -100.0% | -99.3% | +1178.0% |
alltime | all time | -81.3% | >+9999.0% | -99.8% | +125.5% | -99.3% | +166.9% |
Prothena Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $333.00 K(-25.0%) | $2.10 M(-53.2%) |
Jun 2024 | - | $444.00 K(-46.9%) | $4.47 M(-80.3%) |
Mar 2024 | - | $836.00 K(+73.1%) | $22.66 M(-49.8%) |
Dec 2023 | $45.10 M(-81.3%) | $483.00 K(-82.2%) | $45.10 M(-83.0%) |
Sep 2023 | - | $2.71 M(-85.4%) | $265.38 M(-5.5%) |
Jun 2023 | - | $18.63 M(-20.0%) | $280.80 M(+6.6%) |
Mar 2023 | - | $23.28 M(-89.5%) | $263.40 M(+9.1%) |
Dec 2022 | $241.46 M(+26.9%) | $220.76 M(+1117.7%) | $241.46 M(+974.8%) |
Sep 2022 | - | $18.13 M(+1380.0%) | $22.46 M(-75.4%) |
Jun 2022 | - | $1.23 M(-8.4%) | $91.35 M(-17.2%) |
Mar 2022 | - | $1.34 M(-24.6%) | $110.34 M(-42.0%) |
Dec 2021 | $190.33 M(>+9900.0%) | $1.77 M(-98.0%) | $190.33 M(+0.9%) |
Sep 2021 | - | $87.01 M(+330.4%) | $188.56 M(+85.6%) |
Jun 2021 | - | $20.22 M(-75.1%) | $101.61 M(+24.8%) |
Mar 2021 | - | $81.33 M(>+9900.0%) | $81.39 M(>+9900.0%) |
Dec 2020 | $215.00 K(-5.7%) | $0.00(-100.0%) | $215.00 K(-5.7%) |
Sep 2020 | - | $64.00 K(>+9900.0%) | $228.00 K(+39.0%) |
Jun 2020 | - | $0.00(-100.0%) | $164.00 K(-56.1%) |
Mar 2020 | - | $151.00 K(+1061.5%) | $374.00 K(+64.0%) |
Dec 2019 | $228.00 K(-99.4%) | $13.00 K(>+9900.0%) | $228.00 K(-120.9%) |
Sep 2019 | - | $0.00(-100.0%) | -$1.09 M(-47.2%) |
Jun 2019 | - | $210.00 K(+4100.0%) | -$2.06 M(-34.2%) |
Mar 2019 | - | $5000.00(-100.4%) | -$3.13 M(-107.8%) |
Dec 2018 | $40.04 M | -$1.30 M(+33.7%) | $40.04 M(-6.5%) |
Sep 2018 | - | -$975.00 K(+13.2%) | $42.81 M(-7.7%) |
Jun 2018 | - | -$861.00 K(-102.0%) | $46.39 M(-4.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | $43.18 M(+2859.8%) | $48.72 M(-70.5%) |
Dec 2017 | $165.40 M(+7.9%) | $1.46 M(-44.1%) | $165.40 M(-9.7%) |
Sep 2017 | - | $2.61 M(+77.9%) | $183.24 M(-0.9%) |
Jun 2017 | - | $1.47 M(-99.1%) | $184.88 M(+0.4%) |
Mar 2017 | - | $159.87 M(+728.2%) | $184.19 M(+20.2%) |
Dec 2016 | $153.29 M(+11.9%) | $19.30 M(+355.0%) | $153.29 M(+14.8%) |
Sep 2016 | - | $4.24 M(+442.5%) | $133.58 M(+1.2%) |
Jun 2016 | - | $782.00 K(-99.4%) | $131.99 M(-50.2%) |
Mar 2016 | - | $128.96 M(<-9900.0%) | $264.92 M(+93.4%) |
Dec 2015 | $136.99 M(+16.0%) | -$405.00 K(-115.2%) | $136.99 M(-0.3%) |
Sep 2015 | - | $2.66 M(-98.0%) | $137.38 M(-8.0%) |
Jun 2015 | - | $133.71 M(>+9900.0%) | $149.40 M(+26.0%) |
Mar 2015 | - | $1.03 M(-9427.3%) | $118.60 M(+0.4%) |
Dec 2014 | $118.08 M(+39.8%) | -$11.00 K(-100.1%) | $118.08 M(-41.8%) |
Sep 2014 | - | $14.67 M(-85.7%) | $202.75 M(+7.9%) |
Jun 2014 | - | $102.92 M(>+9900.0%) | $187.96 M(+121.0%) |
Mar 2014 | - | $507.00 K(-99.4%) | $85.04 M(+0.7%) |
Dec 2013 | $84.45 M(-49.8%) | $84.65 M(<-9900.0%) | $84.45 M(-40.2%) |
Sep 2013 | - | -$117.00 K(<-9900.0%) | $141.32 M(-5.1%) |
Jun 2013 | - | $0.00(-100.0%) | $148.99 M(-6.5%) |
Mar 2013 | - | -$84.00 K(-100.1%) | $159.39 M(-5.3%) |
Dec 2012 | $168.23 M(+729.1%) | $141.52 M(+1774.0%) | $168.23 M(+529.8%) |
Sep 2012 | - | $7.55 M(-27.4%) | $26.71 M(+39.4%) |
Jun 2012 | - | $10.40 M(+18.7%) | $19.16 M(+118.7%) |
Mar 2012 | - | $8.76 M | $8.76 M |
Dec 2011 | $20.29 M(+73.6%) | - | - |
Dec 2010 | $11.69 M | - | - |
FAQ
- What is Prothena annual cash flow from financing activities?
- What is the all time high annual CFF for Prothena?
- What is Prothena annual CFF year-on-year change?
- What is Prothena quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Prothena?
- What is Prothena quarterly CFF year-on-year change?
- What is Prothena TTM cash flow from financing activities?
- What is the all time high TTM CFF for Prothena?
- What is Prothena TTM CFF year-on-year change?
What is Prothena annual cash flow from financing activities?
The current annual CFF of PRTA is $45.10 M
What is the all time high annual CFF for Prothena?
Prothena all-time high annual cash flow from financing activities is $241.46 M
What is Prothena annual CFF year-on-year change?
Over the past year, PRTA annual cash flow from financing activities has changed by -$196.35 M (-81.32%)
What is Prothena quarterly cash flow from financing activities?
The current quarterly CFF of PRTA is $333.00 K
What is the all time high quarterly CFF for Prothena?
Prothena all-time high quarterly cash flow from financing activities is $220.76 M
What is Prothena quarterly CFF year-on-year change?
Over the past year, PRTA quarterly cash flow from financing activities has changed by -$150.00 K (-31.06%)
What is Prothena TTM cash flow from financing activities?
The current TTM CFF of PRTA is $2.10 M
What is the all time high TTM CFF for Prothena?
Prothena all-time high TTM cash flow from financing activities is $280.80 M
What is Prothena TTM CFF year-on-year change?
Over the past year, PRTA TTM cash flow from financing activities has changed by -$43.01 M (-95.35%)